申请人:ICI Americas Inc.
公开号:US04975435A1
公开(公告)日:1990-12-04
The present invention comprises certain quinoline lactams of formula I; pharmaceutically acceptable salts of the compounds of formula I; pharmaceutical compositions containing a compound of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment of anxiety; and processes for the manufacture of the compounds of formula I, as well as intermediates for use in such manufacture.
本发明涵盖了某些式I的喹啉内酰胺;式I化合物的药学上可接受的盐;含有式I化合物或其药学上可接受的盐的药物组合物,用于治疗焦虑;以及用于制造式I化合物的工艺,以及用于此类制造的中间体。